Both in Biotechnology
Intensity Therapeutics vs Scilex Holding
Over the past year INTS returned −46.3% and SCLX returned −88.5%; their daily moves had a correlation of 0.05.
INTS −46.3% SCLX −88.5%Growth of $1, one year, split-adjusted
| Metric | INTS | SCLX |
|---|---|---|
| Price | $3.38 | $2.09 |
| Market cap | $11.0M | $14.7M |
| Today | +6.29% | +1.95% |
| 1 month | −1.2% | −52.6% |
| 6 months | −34.4% | −75.8% |
| Year to date | −67.0% | −82.9% |
| 1 year | −44.7% | −89.0% |
| Revenue growth (YoY) | — | −22.8% |
| Gross margin | — | 51.9% |
| Net margin | — | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.5× |
| Net cash | $9.5M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 62.5% | 70.2% |
| Short % of float | 2.9% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).